Medicated ghee through nasal and oral intake in the management of Headache disorder (Migraine)

A Comparative Study of Snehapana and Nasya with Panchpal Ghrita in the management of Ardhavbhedaka

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016754

Enrollment

Registered

2018-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere

Interventions

Intervention1: Snehapana with Panchapal Ghrita: snehapana in the dose of 50ml divided in two dose orally in a day will be given for 14 days Control Intervention1: Nasya with Panchapal Ghrita: Nasya ka

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 16-60 years, suffering from Ardhavbhedaka(Migraine) . 2. Patients presenting with sign and symptoms of Ardhavbhedaka described as per Ayurvedic and modern science . 3. Patients who are fit for Snehapana & Nasya karma .

Exclusion criteria

Exclusion criteria: 1.Secondary headache caused due to meningitis , tumour , refractive error , cervical spondylosis 2. Patient suffering from major disease e.g. tuberculosis ,cancer , Diabetes mellitus , Heart. 3. patient using any other systemic drug. 4. Patients who are unfit for Snehapana & Nasya karma . 5. Pregnant and lactating woman .

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective parameterTimepoint: 1 month	—

Secondary

Measure	Time frame
To find the comparative efficacy of the treatments in different groupsTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Aanchal Meena

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University , Jodhpur

drmksharma2007@yahoo.co.in9829695452

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026